本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pacira Pharmaceuticals

24.91
+0.83003.45%
盤後24.910.00000.00%16:04 EDT
成交量:68.61萬
成交額:1,698.03萬
市值:9.93億
市盈率:70.81
高:24.91
開:24.06
低:24.06
收:24.08
52周最高:27.66
52周最低:18.80
股本:3,986.19萬
流通股本:3,636.93萬
量比:1.11
換手率:1.89%
股息:- -
股息率:- -
每股收益(TTM):0.3518
每股收益(LYR):0.1578
淨資產收益率:2.05%
總資產收益率:1.48%
市淨率:1.48
市盈率(LYR):157.83

資料載入中...

2020/01/09

重要事件披露

Current report, items 2.02 and 9.01
2019/11/08

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/10/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/10/09

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/09/30

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/19

重要事件披露

Current report, item 5.02
2019/09/06

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/16

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/16

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/08/08

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/08/08

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/08/08

重要事件披露

Current report, items 2.02 and 9.01
2019/08/05

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/10

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/07/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/07/03

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/06/25

重要事件披露

[Amend] Current report, item 9.01
2019/06/19

持股變動聲明

Initial statement of beneficial ownership of securities
2019/06/19

重要事件披露

Current report, items 5.02 and 9.01